Here's the "indicative only" timeline from the presentation overlaid with scaled monthly intervals showing a targeted return to quotation towards the end of July.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling